药学科学前沿(英文)(Pharmaceutical Science Advances)(国际期刊)(可网站投稿)

《药学科学前沿(英文)》(Pharmaceutical Science Advances,英文简称PHSA)(季刊),杂志于2023年创办,经新闻出版总署批准的正规刊物,是由山东大学主办,山东大学科技期刊社出版, Elsevier出版集团全球发行的同行评议(Peer-Review)和开放获取(Open Access)药学国际学术期刊。期刊以聚焦药学前沿交叉及新药创制为总体目标,旨在贯穿从药学基础理论到应用与技术的上下游全环节,全面展示药学科学,尤其是新药创制工程的前沿成果,为国际药学科学前沿及最新进展提供高水平的学术交流平台。我们欢迎所有药学相关主题的文章,涵盖但不限于以下领域:药理学、制药学、基因组学和蛋白质组学、药物化学、天然产物、药剂学、药物代谢、药物分析、药物动力学、重要药物的临床特征以及制药科学与诸如生物医学工程学、材料科学、管理学、医学伦理学、法学、经济学等跨学科研究成果。

本刊特点:目次收录(知网),外文期刊,

药学科学前沿(英文)(Pharmaceutical Science Advances)(国际刊号)

期刊基本信息

出版周期:季刊 级别:国际刊号
中国国内刊号:无CN刊号
国际标准刊号:ISSN 2773-2169

杂志社联系方式

地址:山东省济南市山大南路27号山东大学
邮编:250100
官方微信公众号:PHSA
官方网站:https://www.sciencedirect.com/journal/pharmaceutical-science-advances

杂志征稿投稿要求

《药学科学前沿(英文)》简介

【微信公众号信息】

Pharmaceutical Science Advances《药学科学前沿(英文)》,(英文简称PHSA,ISSN: 2773-2169)是由山东大学主办,山东大学科技期刊社出版, Elsevier出版集团全球发行的同行评议(Peer-Review)和开放获取(Open Access)药学国际学术期刊。经过近一年的筹备,期刊第一期于2023年3月上线。期刊以提升我国药学科学在国际药学领域的国际话语权和影响力为愿景,以创办综合性药学期刊,聚焦药学前沿交叉及新药创制为总体目标,旨在贯穿从基础理论到应用与技术的上下游全环节,全面展示药学科学,尤其是新药创制的前沿成果,为国际药学科学前沿及最新进展提供高水平的学术交流平台。

PHSA采用快速评审方式审稿,1周内给出初稿意见,1个月内给出同行评审意见。

联系我们

期刊网址:

https://www.journals.elsevier.com/pharmaceutical-science-advances

投稿地址:

https://www.editorialmanager.com/phsa/default2.aspx

编辑部联系方式:

phsa@sdu.edu.cn

投稿指南GUIDE FOR AUTHORS

【杂志社官方网站信息】

Aims and scope

Pharmaceutical Science Advances is a quarterly journal in English, which publishes timely, critical reviews, opinion-based highlights, significant original research articles and rapid communications on topics related to pharmaceutical research, broadly defined, to which the authors have made significant contributions.

Appropriate topics include, but are not limited to, pharmacology, pharmaceutics, genomics and proteomics, medicinal chemistry, natural products, pharmacognosy, drug metabolism, pharmaceutical analysis, pharmacokinetics, and clinical characteristics of important drugs. We are also interested in interdisciplinary research that connects pharmaceutical sciences to, for example, administration, management, ethics, law, economics, as well as biomedical engineering, materials science, mechanology, etc.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

……

更多详情请查看杂志社官方网站信息:

https://www.elsevier.com/journals/pharmaceutical-science-advances/2773-2169/guide-for-authors

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/19977

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 1小时前
下一篇 52分钟前

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息